Literature DB >> 24857564

Distinct profiles of behavioral inhibition and activation system sensitivity in unipolar vs. bipolar mood disorders.

Lena C Quilty1, Laura Mackew2, R Michael Bagby3.   

Abstract

Psychiatric outpatients with mood disorders (n=275) and community controls (n=733) completed a measure of Behavioral Inhibition System (BIS) and Behavioral Activation System (BAS) sensitivity; psychiatric outpatients also completed measures of mood symptom severity. All patients scored higher on BIS compared to controls; patients with bipolar disorders scored higher on BAS scales compared to patients with depressive disorders. BIS and BAS demonstrated unique patterns of association with mood symptoms. Results support the clinical utility of the BIS/BAS.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Behavioral Activation System (BAS); Behavioral Inhibition System (BIS); Depression; Mania; Mood disorders

Mesh：

Year:  2014        PMID： 24857564     DOI： 10.1016/j.psychres.2014.05.007

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


  12 in total

1.  Diminished effort on a progressive ratio task in both unipolar and bipolar depression.

Authors:  Rachel Hershenberg; Theodore D Satterthwaite; Aylin Daldal; Natalie Katchmar; Tyler M Moore; Joseph W Kable; Daniel H Wolf
Journal:  J Affect Disord       Date:  2016-02-16       Impact factor: 4.839

2.  Role of Reward Sensitivity and Processing in Major Depressive and Bipolar Spectrum Disorders.

Authors:  Lauren B Alloy; Thomas Olino; Rachel D Freed; Robin Nusslock
Journal:  Behav Ther       Date:  2016-03-07

3.  Fun Seeking and Reward Responsiveness Moderate the Effect of the Behavioural Inhibition System on Coping-Motivated Problem Gambling.

Authors:  Matthew T Keough; Jeffrey D Wardell; Christian S Hendershot; R Michael Bagby; Lena C Quilty
Journal:  J Gambl Stud       Date:  2017-09

Review 4.  The development and course of bipolar spectrum disorders: an integrated reward and circadian rhythm dysregulation model.

Authors:  Lauren B Alloy; Robin Nusslock; Elaine M Boland
Journal:  Annu Rev Clin Psychol       Date:  2015-01-12       Impact factor: 18.561

Review 5.  Presentation and Neurobiology of Anhedonia in Mood Disorders: Commonalities and Distinctions.

Authors:  Sakina J Rizvi; Clare Lambert; Sidney Kennedy
Journal:  Curr Psychiatry Rep       Date:  2018-03-08       Impact factor: 5.285

Review 6.  Reward processing and mood-related symptoms: An RDoC and translational neuroscience perspective.

Authors:  Robin Nusslock; Lauren B Alloy
Journal:  J Affect Disord       Date:  2017-02-04       Impact factor: 4.839

7.  Common and Dissociable Dysfunction of the Reward System in Bipolar and Unipolar Depression.

Authors:  Theodore D Satterthwaite; Joseph W Kable; Lillie Vandekar; Natalie Katchmar; Danielle S Bassett; Claudia F Baldassano; Kosha Ruparel; Mark A Elliott; Yvette I Sheline; Ruben C Gur; Raquel E Gur; Christos Davatzikos; Ellen Leibenluft; Michael E Thase; Daniel H Wolf
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

8.  A Multimethod Examination of Sensitivity to Reward and Sensitivity to Punishment in Bipolar Disorder and Alcohol Dependence: Results from a 2 × 2 Factorial Design.

Authors:  William Mellick; James J Prisciandaro; Helena Brenner; Delisa Brown; Bryan K Tolliver
Journal:  Psychopathology       Date:  2021-02-17       Impact factor: 1.944

9.  A pathway linking reward circuitry, impulsive sensation-seeking and risky decision-making in young adults: identifying neural markers for new interventions.

Authors:  H W Chase; J C Fournier; M A Bertocci; T Greenberg; H Aslam; R Stiffler; J Lockovich; S Graur; G Bebko; E E Forbes; M L Phillips
Journal:  Transl Psychiatry       Date:  2017-04-18       Impact factor: 6.222

10.  The Role of Motivation in Cognitive Reappraisal for Depressed Patients.

Authors:  Xiaoxia Wang; Xiaoyan Zhou; Qin Dai; Bing Ji; Zhengzhi Feng
Journal:  Front Hum Neurosci       Date:  2017-10-31       Impact factor: 3.169
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.